Placental site trophoblastic tumor (PSTT) is a rare type of gestational tro
phoblastic disease with potential malignant behavior. Prognostic factors in
clude extrauterine spread, time since antecedent pregnancy, age, and (possi
bly) the mitotic count. Because of low chemosensitivity, resection of the p
rimary tumor is considered to be the cornerstone of adequate therapy [1,2].
If complete resection of the tumor is achieved, an excellent prognosis can
be expected. In cases with distant metastases or residual disease, aggress
ive multiagent chemotherapy is required. The prognosis in these cases is un
favorable. Because of possibly long latency until the recurrence of PSTT, l
ong-term follow-up is required.